Adam Milstein, a Pro-Israeli Activist

Adam Milstein is the president of the Adam and Gila Milstein Family Foundation, a philanthropic institution that focuses on sponsoring Jewish students and professionals to pursuing further education. Being an Israeli native, Adam Milstein has been working towards bringing sanity to the agendas affecting his birth country, Israel, through discussions on his podcast. He also served in the Israel army during the Yom Kippur War but later on moved to the U.S. with his family. In 1983, he received a master’s degree in business administration and started off his real estate career in Southern Carolina. Currently, he is a managing partner of a private, commercial real-estate firm called Hager Pacific Properties. The company manages and owns more than a million square feet of industrial and commercial real estate throughout the U.S.

Adam Milstein has established himself as a household name and works best by partnering with organizations that are looking to be influential and efficient. He is also known to be philanthropic with more than just financial gain. Adam is involved in expert consultation, fundraising and partnership development for most Jewish support programs. Being a pro-Israel advocate, he also sits in different organization boards, including American Israel Public Affairs Committee National Council, Jewish Funders Network, Stand by Me, Hasbara Fellowships and many others.

Through his foundation, he has created a synergy and culture of collaboration and cooperation for the Israeli activist community. As a result, he has been able to reach a wider audience and proven to have profound impact on the American-Israeli community. The programs being run by the foundation not only focus on influencing lives today but also ensure that they capture the attention of people from different age groups, including childhood and adolescence. In the non-profit world, he has been recognized as a fixture and thoughtful leader that desires to share insights for the better part of his life.

In his podcast, he always features conversations with activists, artists, thinker, policymakers and elected officials regarding pro-Israeli, Jewish-American and Israeli-American communities. Through the same media platform, Adam Milstein has managed to give in-house information regarding the different issues facing Israel, including how the country is engaging with young adults on political movements, the progress towards the Boycott, Divestment and Sanctions movement, among others pertinent issues.

Adam Milstein, a Pro-Israeli Activist

Treating Cancer with Clay Siegel’s Approach

Contemporary cancer treatment breakthrough

Cancer being one of the diseases known to have a high mortality rate has led to the desperate moves by medical practitioners to find ways of controlling it. Some of the most revolutionary scientific methods have actually been employed in the fight against this atrocious disease. Such methods include the use of antibody-based therapies in pursuit of optional treatments for it. As new treatments for cancer develop, Antibody Drug Conjugates is the best known effective approach in cancer treatment. This is mainly because the approach targets specific conditions with uttermost power. Therefore, the drug-based research on cancer treatment remains one of the most promising approaches in the global fight against this feared condition.

Siegall significance in the advancement of cancer treatment

In regard to the search for a solution to cancer which the world faces in the 21st century, Clay Siegall has been on the forefront to fight back. He is the CEO and chairman of Seattle Genetics, a well reputable and globally acclaimed champion in the fight against cancer. He founded the company in 1998 and became its first CEO and chairman of the board. Due to his exemplary innovative ideas, he was awarded the accelerated approval by FDA in the year 2011. The US Food and Drug Authority deemed it fit to have the Ph.D. holder approved to deal with issues touching on genetics.

  1. Clay Siegall attained his Ph.D. in genetics from the Gorge Washington University. This was after graduating with a Bachelor of Science in Zoology from the University of Maryland. The good doctor has been in the industry for long gathering information and experience over the years. This has enabled him to develop more than 50 publications while holding patents to at least 15 of them. He was behind the $657 million public/private financing of his company in the year 2001. Long before he founded his company, Dr. Siegall had a long career of close to a decade at the Bristol-Myers Squibb Pharmaceutical Research institute.
Treating Cancer with Clay Siegel’s Approach